Tag: Amgen

Amgen Successfully Completes Acquisition Of Five Prime Therapeutics

Amgen Announces Positive Top-Line Results From Otezla® (apremilast) Phase 3 ADVANCE Study

FDA Grants Fast Track Designation For Omecamtiv Mecarbil In Heart Failure

Amgen And Adaptive Biotechnologies Announce Strategic Partnership To Develop A Therapeutic To Prevent Or Treat COVID-19

Amgen’s AVSOLA™ received FDA approval for AVSOLA™ (infliximab-axxq), For The Same Indications As Remicade® (infliximab)for the treatment of Rheumatoid Arthritis, Crohn’s Disease, Ulcerative Colitis,...

Initiation Of First Large-Scale Registry :To Evaluate Real-World Lipid Management And The Effectiveness Of PCSK9 Inhibitors